Sign in
8-K/A

Current Report

Damora Therapeutics, Inc. Filed Acc 0001193125-25-312912

Bylaws or fiscal year change

  • Item 5.03 Amendments to articles or bylaws; change in fiscal year

From the SEC's structured data for this filing

Loading glto-20251110.htm…